Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ligustrum robustum is a plant species in the Oleaceae family, traditionally used in Chinese folk medicine and as an herbal tea known as Ku-Ding-Cha. The leaves are consumed for their purported health benefits including "clearing heat," removing toxins, and treating conditions such as hypertension, diabetes, obesity, and fever. Pharmacological studies have demonstrated that extracts from the leaves possess antipyretic (fever-reducing), antioxidant, anti-obesity, antidiabetic, cytoprotective (cell-protecting), and potential anti-cancer activities. Mechanistically, bioactive compounds isolated from L. robustum inhibit fatty acid synthase (FAS), α-glucosidase, and α-amylase—enzymes involved in lipid and carbohydrate metabolism—suggesting possible roles in metabolic disease prevention or management. The plant's polyphenols also exhibit strong free radical scavenging activity[3][4][5][6][7]. It is not a pharmaceutical drug but rather a dietary supplement or functional food ingredient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ligustrum robustum.